English | Español

Bristol-Myers Squibb
Jamie Barrand | Feb 23, 2016

Bristol-Myers Squibb's hepatitis C study focuses on Asian populations
Jamie Barrand | Feb 18, 2016

Pharmaceutical partnership to focus on high-risk cancer research
Jamie Barrand | Feb 10, 2016

FDA expands label for Bristol-Myers Squibb's Daklinza therapy
Jamie Barrand | Feb 4, 2016

Pharmaceutical companies investigate anticoagulant agent to reduce strokes
Caitlin Nordahl | Jan 29, 2016

FDA expands approved use of Bristol-Myers Squibb’s late-stage melanoma treatment
Kasey Schefflin- Emrich | Jan 26, 2016

Bristol-Myers Squibb recognized for advancing multiple myeloma research
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb sells HIV therapy portfolio to ViiV Healthcare
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb gives $397,422 to help launch military transition project

Trending
Patient Daily | Aug 12, 2025

Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’
+ Regulatory
Patient Daily | Aug 14, 2025

Founder of Policy Candy: '340B must see comprehensive reforms'
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+ Pharmaceuticals
Patient Daily | Aug 14, 2025

PhRMA COO on 340B: 'Hidden tax on patients, taxpayers & employers'